[imageframe lightbox=”no” lightbox_image=”” style_type=”dropshadow” hover_type=”none” bordercolor=”” bordersize=”0px” borderradius=”0″ stylecolor=”” align=”left” link=”” linktarget=”_self” animation_type=”0″ animation_direction=”down” animation_speed=”0.1″ class=”” id=””][/imageframe]Kevin McRaith, CEO, is guiding the WellDoc team in the successful launch and continued development of the BlueStar Mobile Prescription Therapy. Under his leadership, the WellDoc team has engineered an innovative commercial approach to BlueStar’s positioning in the marketplace, and achieved success in the initial targeted launch of BlueStar.
Prior to joining WellDoc in 2014, Kevin served as Vice President of Sales and Marketing at Human Genome Sciences. In his leadership role with Human Genome Sciences, Kevin hired and led the commercial organization responsible for the successful launch of Benlysta. Kevin also served as Vice President of Sales and Marketing at Hematology Franchise at Genentech where he led the team through the strategic development and sales and marketing execution for Rituxan®. Prior to his tenure at Genentech, Kevin held numerous sales and marketing roles of increasing responsibility over 14 years at Abbott Laboratories where he worked on key product launches, including Depakote®, Biaxin®, Kaletra®, Micardis® and Tricor®. His last role at Abbott was General Manager of the Anti-Infective franchise. Prior to Abbott, Kevin started his career at Baxter Healthcare, where he held various roles in sales and marketing.